Last reviewed · How we verify
NCT06908915: Nd:YAG
Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions
NA trial testing Nd:YAG laser 1064 nm in Rosacea, Erythematotelangiectatic in 30 participants. Completed in 4 November 2024.
1 November 2023
Quick facts
| Lead sponsor | Hawler Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 3 March 2023 |
| Primary completion | 1 November 2023 |
| Estimated completion | 4 November 2024 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Nd:YAG laser 1064 nm
Conditions studied
- Rosacea, Erythematotelangiectatic — all drugs for Rosacea, Erythematotelangiectatic →
Sponsor
Hawler Medical University
Who can join
Adults 32 to 52, any sex, with Rosacea, Erythematotelangiectatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia. The used parameter of this laser was of very low energy (spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 millijoules (mJ) and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval) and also its was expected to have minimal adverse effects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06908915
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rosacea, Erythematotelangiectatic
Currently open trials in the same condition.
- NCT06801717 — Rosacea Radiofrequency Microneedling · NA · recruiting
Other Hawler Medical University trials
Trials by the same sponsor.
- NCT07066930 — Optimizing Alveolar Ridge Expansion · NA · not yet recruiting
- NCT07047742 — Efficacy of Dietary Interventions and Educational Programs as Adjunctive Therapies for the Management of Urolithiasis: E · NA · not yet recruiting
- NCT07467616 — Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis. · NA · completed
- NCT07380776 — Preoperative Education Program on Gastrointestinal Quality of Life in Cholecystectomy Patients · NA · active not recruiting
- NCT06642337 — Nutritional Educational Program On Therapy in Iron Deficiency Anemia · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06908915 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hawler Medical University
- Last refreshed: 3 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06908915.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing